Health Discovery Corporation carries a market capitalization of 41,171.00, placing it among publicly traded companies globally. Its enterprise value stands at 72.35M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 41,171.00 |
| Enterprise Value | 72.35M |
Health Discovery Corporation currently has 411.71M shares outstanding.
| Shares Outstanding | 411.71M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Health Discovery Corporation trades at a trailing price-to-earnings ratio of 31.80.
| PE Ratio | 31.80 |
| PS Ratio | N/A |
| PB Ratio | -90.35 |
| P/TBV Ratio | -90.35 |
| P/FCF Ratio | -58.17 |
| P/OCF Ratio | -58.17 |
Health Discovery Corporation maintains a current ratio of 0.33, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -36.43, indicating conservative leverage, while an interest coverage ratio of -170.41 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.33 |
| Quick Ratio | 0.31 |
| Debt / Equity | -36.43 |
| Debt / EBITDA | -0.07 |
| Interest Coverage | -170.41 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -368.63 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Health Discovery Corporation's stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
EBITDA reached -2.90M, while operating income came in at -2.90M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -2.90M |
| Pretax Income | -2.91M |
| Net Income | -2.91M |
| EBITDA | -2.90M |
| EBIT | -2.90M |
| Earnings Per Share (EPS) | -0.01 |
Health Discovery Corporation holds 270,000.00 in cash and equivalents against 212,000.00 in total debt, resulting in a net debt position of -58,000.00. Total book value stands at -799,000.00, with working capital of -582,000.00 providing operational flexibility.
| Cash & Cash Equivalents | 270,000.00 |
| Total Debt | 212,000.00 |
| Net Debt | -58,000.00 |
| Equity (Book Value) | -799,000.00 |
| Book Value Per Share | 0.00 |
| Working Capital | -582,000.00 |
Health Discovery Corporation produced -1.24M in operating cash flow over the past twelve months.
| Operating Cash Flow | -1.24M |
| Capital Expenditures | N/A |
| Free Cash Flow | -1.24M |
| FCF Per Share | 0.00 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.30 |
| FCF Yield | -1.72 |
Health Discovery Corporation posts an Altman Z-Score of -146.64, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -146.64 |